awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35539538-30B5CAC5-6A11-4382-8AED-53FF7D403501
Q35539538-30B5CAC5-6A11-4382-8AED-53FF7D403501
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35539538-30B5CAC5-6A11-4382-8AED-53FF7D403501
Response evaluation after primary systemic therapy of Her2 positive breast cancer – an observational cross-sectional study
P2860
Q35539538-30B5CAC5-6A11-4382-8AED-53FF7D403501
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35539538-30B5CAC5-6A11-4382-8AED-53FF7D403501
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e1947b9fad5040ac57645d09786dddeb0f372c94
P2860
Neoadjuvant therapy with paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide chemotherapy and concurrent trastuzumab in human epidermal growth factor receptor 2-positive operable breast cancer: an update of the initial randomized